Right ventricular (RV) function is an important determinant of outcomes in pulmonary hypertension (PH). RV-arterial coupling ratio using stroke volume (SV) to end-systolic volume (ESV) has been shown to be an independent predictor of outcome in adults with PH. SV/ESV has not been used in pediatrics to predict outcomes. We compared SV/ESV between pediatric patients with PH, controls, and among groups based on disease severity. We correlated SV/ESV to RV strain and evaluated SV/ESV as a predictor of outcomes in pediatric PH.
P
ediatric pulmonary hypertension (PH) is an incurable disease with a poor prognosis. 1 The main cause of mortality is right ventricular (RV) failure with inability of the RV to maintain cardiac output with increasing arterial afterload, thus decoupling of the ventricular-vascular system. The RV adapts to increasing afterload by enhancing contractility to maintain flow. 2, 3 RV-arterial coupling ratio has been evaluated by invasive cardiac catheterization measures using pressurevolume loop and single-beat method. 4, 5 This ratio has also been evaluated using cardiac magnetic resonance imaging (CMRI). [6] [7] [8] [9] However, both cardiac catheterization and CMRI often require sedation in pediatric population and is not readily available at the bedside.
Three-dimensional echocardiography (3DE) is readily available and is noninvasive. 3DE determined RV volumes and ejection fraction (EF) correlate strongly with cardiac MRI when evaluating for RV volumes and function. 10, 11 Noninvasive measures of RV function include 2-dimensional (2D) fractional area change (FAC), RV EF, and RV strain. [12] [13] [14] [15] [16] RV strain from prior studies have shown that it may be a potential early marker of prognosis before other RV functional indices are abnormal. 17, 18 However, these measures do not take into account the ventricular-arterial interaction in PH. In the presence of chronic increase afterload, the RV adapts by progressive increase in contractility to maintain cardiac output. 7 Thus, a determination of RV function must include estimations of contractility and afterload. RV contractility is determined by the slope of end-systolic pressure versus the end-systolic volume (ESV) and is called end-systolic elastance (Ees). 5, [19] [20] [21] RV afterload can be estimated from the pressure-volume relation as arterial elastance (Ea) with end-systolic pressure divided by the stroke volume (SV). 19 Ees/Ea represents the ventriculoarterial coupling ratio that can be further simplified for pressure and expressed as SV/ESV ratio. 9 Using SV/ESV as a volume estimate of RV-arterial coupling ratio has been shown to be an independent predictor of outcome in adults with PH and has been shown to be more sensitive than RV EF to changes in function early in disease. [7] [8] [9] 22 SV/ESV ratio has not been used in pediatric patients with PH to evaluate outcomes. We aimed (1) to compare SV/ESV between pediatric patients with PH and controls, (2) to compare SV/ESV between different groups of patients with PH and disease severity, (3) to evaluate the relationship of SV/ESV to RV longitudinal strain (LS), and (4) to evaluate SV/ESV for prediction of clinical outcomes in pediatric PH.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Population
The medical records were retrospectively reviewed for pediatric patients with PH from 2014 to 2017. Patients with PH were evaluated for study inclusion if they had a diagnosis of idiopathic pulmonary artery hypertension (IPAH) and associated pulmonary artery hypertension with congenital heart disease (APAH-CHD) by cardiac catheterization with a mean pulmonary artery pressure >25 mm Hg and pulmonary vascular resistance >3 Woods units, had a routine 2D echocardiogram in addition to 3DE, and were seen in the PH clinic. World Health Organization functional classifications (WHO-FC) were identified in each patient at clinic visits. Patients were excluded if they were >18 years of age and if the echocardiographic images were poor for adequate tracing of the endocardial borders. Normal pediatric patients served as controls who had no cardiac defects or family history of cardiac disease or they were patients who were evaluated in the cardiology clinic for heart murmurs, chest pain, or syncope with normal structure hearts. This study was approved by the Institutional Review Board at the University of Colorado.
Three-Dimensional Echocardiography
Single-beat full volumes of 3DE RV datasets were acquired using the 4Z1c matrix-array transducer (frequency bandwidth, 1.5-3.5 MHz; maximum depth, 30 cm; maximum field of view, 90×90°) on the Siemens SC2000 cardiac ultrasound system (Siemens Healthcare, Erlangen, Germany). An apical 4-chamber view was acquired with the patient in the lateral decubitus position. The transducer position was modified for optimal simultaneous visualization of the tricuspid valve, cardiac apex, infundibulum, and RV outflow tract (Movie I in the Data Supplement). 3DE RV datasets were digitally analyzed offline using the commercial
CLINICAL PERSPECTIVE
We investigated right ventricular (RV) arterial coupling ratio using stroke volume (SV) to end-systolic volume (ESV) in pediatric patients with pulmonary hypertension compared with normal controls and with disease severity. We correlated SV/ESV to RV strain and evaluated SV/ESV as a predictor of outcomes in pediatric pulmonary hypertension. Our results demonstrated that SV/ESV ratio is decreased compared with controls and with disease severity. SV/ESV as a volume estimate of RV-arterial coupling ratio correlates with RV strain and is a strong predictor of adverse clinical events in pediatric pulmonary hypertension. This ratio may provide incremental value to RV functional measures alone because it allows for understanding of cardiopulmonary vascular unit as a whole system and the effect of afterload to the RV in patients with pulmonary hypertension.
software (4D RV-Function 2.0; TomTec Imaging Systems, Unterschleissheim, Germany) to generate RV volumes and functional indices automatically: 3-dimensional (3D) enddiastolic volume, 3D ESV, 3D SV, 3D EF, FAC, and free-wall (FW) RV LS ( Figure I in the Data Supplement). For clarity, we will refer FAC derived from the 3D datasets as 3D FAC to differentiate from 2D FAC that is traced from 2D echocardiograms.
Determination of RV-Arterial Coupling Ratio
Using the Sanz method, the Ees/Ea ratio has a common pressure term and can thus be simplified in the following equation (see the Data Supplement for full equation) 9 :
Clinical Outcomes
Clinical outcomes were analyzed in all patients with PH with predefined adverse clinical events. An adverse clinical event was defined as (1) new initiation of intravenous prostacyclin, (2) PAH-related hospitalization with increased RV failure or hemoptysis, (3) creation of an atrial septostomy, (4) performance of a Pott shunt, (5) performance of lung transplantation, or (6) death. These adverse clinical outcomes were composite end points similar to previous medication trials in PAH. 23 All patients were followed up until the clinical event or the end of the study period.
Statistical Analysis
Analyses were performed using SAS 9.4 and JMP 13.0. Variables were checked for the distributional assumption of normality using normal plots, in addition to KolmogorovSmirnov and Shapiro-Wilk tests. All normally distributed group-specific data sets are reported as mean with corresponding SDs. Nonnormally distributed values are reported as median values with corresponding interquartile ranges.
RV volumes, EF, SV/ESV, and FW RV LS were compared between controls, IPAH, and patients with APAH-CHD PH using either 1-way ANOVA or Kruskal-Wallis as dictated by distribution. RV volumes, EF, SV/ESV, and FW RV LS were also compared between patients with PH with different WHO-FC. Correlations between SV/ESV to 2D FAC, 3D FAC, and FW RV LS were assessed using general linear mixed models adjusted for age, sex, and body surface area. Mixed model analysis using subjects with at least 2 repeated measures were also performed.
Composite hard outcomes were defined as death, lung transplantation, initiation of intravenous/subcutaneous prostacyclin therapy, PAH-related hospitalization with increased RV failure or hemoptysis, clinically indicated atrial septostomy, or need for a Pott shunt. Kaplan-Meier survival curve was used to describe the survival behavior of time from echocardiographic study to this composite outcome. Association of SV/ESV with outcomes was assessed using Cox regression model while adjusting for age, body surface area (BSA), and sex of patient. Discriminating ability of Cox regression model was assessed by time-dependent integrated area under receiver operating characteristic (ROC) curve and Uno C statistic. 24 Integrated area under ROC curves is a summary statistic for area under ROC curves of the follow-up period, and this was performed in all RV parameters (2D FAC, RV volumes, RV EF, 3D FAC, SV/ESV, and FW RV LS). Comparison of C statistics with SV/ESV based on model adjusting for age, sex, and BSA was performed. All patients were followed up to the particular event or the end of the study (December 2017). A subanalysis of outcomes using Kaplan-Meier survival curve, Cox regression model (adjusted for age, BSA, and sex of patient), and ROC was performed in patients with IPAH. Significance was based on an α-level of 0.05. The ICC for interobserver and intraobserver variability had been reported in our previous article.
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RESULTS
Patients With PH and Controls
There were 125 patients with PH with IPAH and APAH-CHD from 2014 to 2017 with 328 echocardiographic studies. There were 9 patients with PH excluded because of poor image quality (7%). Sixty-five normal pediatric patients served as controls. Figure 1 ). There was statistically significant difference between the RV volumes in IPAH, APAH-CHD, and controls (Table 2) .
RV-Arterial Coupling Ratio and Strain Relationship in Patients With PH
The SV/ESV ratio was found to be lower in patients with PH with worse WHO-FC. Table 3 and Figure 2 showed that patients with WHO-FC III+IV had SV/ESV ratio significantly different from I and II (P<0.02 and P<0.001, respectively) but no statistically significant differences between patients of WHO-FC I compared with WHO-FC II (P=0.364). Although there were statistically significant correlations of SV/ESV to 2D FAC, the correlation was poor (Table 4) . 3D FAC had stronger correlation to SV/ESV compared with 2D FAC. There were statistically significant associations between RV SV/ESV to FW RV LS (r=−0.53; P<0.001; Figure 3 ). Mixed model analysis using subjects with at least 2 repeated measures also found the significant negative association between FW RV LS and SV/ESV ratio ( Figure 4) . Specifically, for every 0.1 increase in SV/ESV, FW RV LS decreased by 1.74% (P<0.001).
Clinical Outcome Analysis
This cohort of 125 patients with PH was followed for a median of 18.3 months, ranging from 0.03 to 41.7 months. Of 125 enrolled subjects, 67 (54%) had repeated measures. The number of repeated measures range from 2 to 10 with a median of 3. There were 20 adverse clinical events (11 in females and 9 in males). Two patients died, 3 underwent Pott shunt, 3 underwent clinically indicated septostomy, 7 were started on IV prostacyclin therapy, and 5 had PAH-related hospitalization. Data are represented as median (interquartile range). APAH-CHD indicates associated pulmonary artery hypertension with congenital heart disease; ASD, atrial septal defect; AVSD, atrioventricular septal defect; BSA, body surface area; CCB, calcium channel blocker; CoA, coarctation of the aorta; ERA, endothelin receptor antagonist; IPAH, idiopathic pulmonary artery hypertension; IV, intravenous; LPA, left pulmonary artery; PAPVR, partially anomalous pulmonary venous return; PDA, patent ductus arteriosus; PDE5i, phosphodiesterase-5 inhibitor; PH, pulmonary hypertension; PVS, pulmonary venous stenosis; RPA, right pulmonary artery; SC, subcutaneous; s/p, status post; TAPVR, total anomalous pulmonary venous return; TGA, transposition of great arteries; VSD, ventricular septal defect; and WHO-FC, World Health Organization functional classifications. verse clinical event for every 0.1-unit decrease of SV/ESV. Figure 6 depicted several survival curves predicted by Cox model to display different values of SV/ESV ratio after adjusting for age, BSA, and sex. The survival curves were similar in both males and females with different values of SV/ESV ratio ( Figure 6 ). This model is of strong discriminating ability. The Uno C statistic summary for SV/ ESV ratio is 0.77 and for other RV parameters is listed in Table 5 . Comparison of C statistics between SV/ESV and each of the other RV parameters shows no significant evidence that SV/ESV is either superior or inferior to other predictors (Table 6 ). Figure II in the Data Supplement depicts the ROC curves from the Cox regression of SV/ESV at time to event at 6, 12, 18, and 24 months. 
DISCUSSION
This study demonstrated (1) that pediatric patients with PH have worse RV-arterial coupling ratio com- pared with controls, (2) that they have worse SV/ESV with increasing disease severity, (3) that this ratio has an inverse relationship with RV strain, and (4) that SV/ ESV can be a predictor of adverse clinical events in pediatric PH. The RV initially adapts to increased afterload by increasing its contractility. 5, 7, 9 The pulmonary vascular resistance may increase by factor of 4-to 5-fold, and coupling is maintained by a 4-to 5-fold increase in contractility of the RV. 3 An important mechanism to achieve this increase is to increase Ees by ventricular hypertrophy. 3 The normal adaptation of the RV in the early stages of PH is RV hypertrophy, which is beneficial for the systolic function of the RV with only a slight decrease in RV-arterial coupling ratio. 25 But this adaptation ceases in late stages because of progressively rise in afterload and the SV decreases. 3 To maintain the SV, the RV will dilate. 3 However, an attempt to maintain cardiac output with decreasing SV, the heart rate will increase. Because Ea=pulmonary vascular resistance×heart rate, the Ea will increase resulting in an Ees/Ea ratio to decrease. 3 This maladaptation and ventricular-vascular mismatch occurs with severe fall in RV-arterial coupling ratio leading to RV failure and death. 26 Our study using SV/ESV as a volume estimate of RV-arterial coupling ratio demonstrated that patients with PH have lower SV/ESV ratio when compared with controls. Although we separated the patients with PH into IPAH and APAH-CHD, we did not see a difference in the SV/ESV ratio between these subgroups. Patients with PH with worse WHO-FC also have lower SV/ESV ratio indicating that SV/ESV can be used as a marker for disease severity.
We demonstrated that the SV/ESV ratio is associated with FW RV LS. As RV-arterial coupling ratio decreases, so does the function of the RV. This inverse relationship is maintained over time with repeated measures as shown in Figure 4 . Previous studies have shown that RV strain may be a potential early marker of prognosis before other RV functional indices are abnormal. 17, 18 The association of SV/ESV with RV strain may also indicate that SV/ESV ratio may also be an early marker of prognosis. Further, as PH progresses, SV/ESV is a better predictor of adverse events than FW RV LS as demonstrated in Figure 7 . We found poor correlation of SV/ESV to 2D FAC likely because SV/ESV is a volume estimate of the RV-arterial coupling, whereas 2D FAC is an estimated measure of RV function. The FAC derived from 3D dataset had better correlation to SV/ESV because the cut plane of the 2D image derived from the 3D dataset is constant, whereas the angulation of the probe while acquiring 2D image of the 4-chamber view may vary between sonographers when obtaining 2D FAC.
SV/ESV ratio can be a predictor of adverse clinical events in our pediatric patients with PH. Vanderpool et al 7 described using this ratio derived from CMRI to predict outcomes in adults with PH. Truong et al 6 described using this ratio from CMRI in 17 pediatric patients with PH and demonstrated that this ratio was feasible from CMRI when compared with cardiac catheterization single-beat method. Because cardiac catheterization is invasive and CMRI requires anesthesia in children, a noninvasive evaluation of the cardiopulmonary vascular unit using 3DE is desirable and could provide earlier detection of RV failure. 3DE can be obtained at the bedside and is easily performed. Our study demonstrated that for every increase in 0.1 unit of SV/ESV ratio, there is a decrease of 48% of having adverse clinical events. This ratio is also sensitive and specific in detecting adverse clinical events in pediatric patients with PH. Similar results were found when stratifying patients with PH to IPAH group when evaluating for outcomes.
Although RV EF and RV strain allow for quantification of RV function, an understanding of the afterload effect on the RV is valuable and may add incremental value to RV functional measures alone. Both RV EF and RV strain are load-dependent measures, whereas Ees is a load-independent measure of ventricular function, and Ea is a measure of afterload faced by the RV. 2, 3, 27 Coupling can be assessed from the ratio between Ees/ Ea and is a measure of energy transfer from the RV to the pulmonary arteries. 3 The volume method using SV/ ESV as an estimate of RV-arterial coupling ratio of Ees/ Ea was demonstrated by Sanz et al 9 and subsequently by Vanderpool et al. 7 In Vanderpool study, the SV/ESV was prognostically superior to invasive measurements provided by right heart catheterization. 7 Brewis et al 8 subsequently demonstrated that SV/ESV predicted outcomes better in adult patients with PH than using invasive measurements. Our study is the first to use 3DE to evaluate RV-arterial coupling ratio in pediatric PH. Although we demonstrated in our prior work that RV EF and strain are good predictors of outcome in pediatric PH, the area under the curves are not as high as they are for SV/ESV ratio in the current study as demonstrated in Figure 8 and in our prior study. 14 Vanderpool et al 22 found that SV/ESV may be more sensitive than EF to changes in RV function in more severe PH. This ratio includes the information about RV EF but in a less preload-dependent manner. 28, 29 This ratio also allows for understanding of cardiopulmonary vascular unit as a whole system and the effect of afterload to the RV in patients with PH. Further studies to use this SV/ESV ratio to evaluate treatment effectiveness and to follow patients over time would need to be explored in pediatric PH.
Limitations
This study has the following limitations. First, we used a big size probe of the Siemens machine and single-beat 3DE because it does not require breath-hold in pediatric patients. Despite this limitation, single-beat 3DE acquisition generated from the Siemens machine has a higher volume rate than other vendor machines and is advantageous over traditional disk summation that require serial heartbeat acquisitions resulting in stitch artifacts. The development of a pediatric 3D transthoracic probe for single-beat acquisition could help resolve the technical limitations. Second, limitations to this study include those inherent to a retrospective study. Third, the volume method of SV/ESV is an Ees/Ea ratio simplified for pressure. This ratio assumes that RV volume at zero filling pressure would be equal to zero, which is unrealistic and SV/ESV will underestimate the true Ees/Ea. 30 However, studies have shown that SV/ ESV have outperformed pressure measurements of RV-arterial coupling ratio in predicting outcomes in patients with PH.
7,8
Conclusions
Progressive increase in afterload causes RV dysfunction in pediatric patients with PH. SV/ESV as a volume estimate of RV-arterial coupling ratio correlates with RV 
